STXBP1 Foundation Awards Innovation Grant to Scott Baraban for High-throughput Drug Screen in Zebrafish
STXBP1 Foundation Awards Innovation Grant to Kyle Fink for CRISPR activation Gene Therapy
STXBP1 has an ICD-10 Code!
Capsida Receives FDA Fast Track Designation for Its Potential First-in-Class IV-Administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy
Capsida receives FDA IND Clearance for its first-in-class, IV-administered gene therapy for STXBP1-developmental and epileptic encephalopathy
5 Marathons in 5 Days for Charlie
Capsida Presents New GLP Toxicology Data Supporting Recent FDA IND Clearance of Its First-in-Class, IV-administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy
Capsida Receives FDA IND Clearance for Its First-in-Class, IV-administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy
Capsida to Present Progress Updates on CAP-002 at the ASGCT Annual Meeting
